Biotech M&A is heating up, and Mirum Pharmaceuticals stands out. Discover why analysts predict a 50% upside and long-term ...
A 33-year-old piece of legislation in Australia is helping to spark fresh interest from private equity firms including KKR & ...
If necessity is the mother of invention, fans of financial engineering have a treat in store from private equity titans in ...
Legend Biotech is a commercial-stage biotech company specializing in innovative cell therapies. Click here to find out why I ...
Japan's economy minister Ryosei Akazawa has connected the potential acquisition of retail giant Seven & i by Canada's ...
A group of lenders including Goldman Sachs Group Inc. are preparing €1.1 billion ($1.2 billion) of leveraged financing to ...
Arcadium Lithium shares were up 9% to $5.73 after the company said the Committee on Foreign Investment in the U.S. concluded its review of the proposed acquisition of Arcadium Lithium by Rio Tinto and ...
Insignia manages A$319 billion across its sprawling portfolio. That includes billions in retirement savings across a range of ...
GlobalData on MSN2d
Insignia Financial gets $1.8bn buyout bid from CC CapitalThe latest offer is contingent on satisfactory due diligence, a unanimous board recommendation, and regulatory approvals.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback